GL1X · GenesisL1 explorer

Research workbench

Human kynurenine aminotransferase I in complex with tris

Analyse Human kynurenine aminotransferase I in complex with tris in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FVX
Type
protein
Length
838 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kynurenine--oxoglutarate transaminase 1
EC
2.6.1.7, 2.6.1.64, 4.4.1.13
UniProt
Q16773
Ligands
NA
Pockets
10 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BKynurenine--oxoglutarate transaminase 1 (EC 2.6.1.7, 2.6.1.64, 4.4.1.13)protein41947% helix, 15% strandQ16773

Ligands and binding sites

  • NA · Sodium ion · metal · 2 copies · chains A, B
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.730.9920empty
23300.730.8544empty
34490.710.8154TRS
42230.640.8335empty
51820.580.8125empty

Interfaces

1 interface between chains.

  • A–B · 3154 Ų buried · 58 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (cofactor).

Compared structures

  • 3FVX · Human kynurenine aminotransferase I in complex with tris · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16773 · AlphaFold monomer V2.0 prediction for kynurenine--oxoglutarate transaminase 1 (Q16773) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.